DENNIS DUMA: Open Payments
NPI 1598377020 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 60 payments from 10 companies in 2025. Trend: 2023 $79 · 2024 $686 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $267 |
| Phathom Pharmaceuticals, Inc. | 16 | $112 |
| Madrigal Pharmaceuticals | 3 | $80 |
| Organon LLC | 4 | $48 |
| Ardelyx, Inc. | 2 | $30 |
| Janssen Biotech, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| EVOKE PHARMA, INC. | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VOQUEZNA, MAVYRET, REZDIFFRA, LINZESS, CREON, IBSRELA, TREMFYA, ZENPEP.
Industry payments across FL — which companies pay providers there.
